CHD7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.931800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.863400E-01
Normal-vs-Stage2
4.990800E-01
Normal-vs-Stage3
3.317400E-01
Normal-vs-Stage4
5.070400E-01
Stage1-vs-Stage2
8.706600E-01
Stage1-vs-Stage3
1.534190E-01
Stage1-vs-Stage4
8.640800E-01
Stage2-vs-Stage3
1.335360E-01
Stage2-vs-Stage4
9.842200E-01
Stage3-vs-Stage4
1.026590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.963800E-01
Normal-vs-AfricanAmerican
5.134600E-01
Normal-vs-Asian
4.198200E-01
Caucasian-vs-AfricanAmerican
9.452600E-01
Caucasian-vs-Asian
3.014400E-01
AfricanAmerican-vs-Asian
5.015200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.033400E-01
Normal-vs-Female
4.839600E-01
Male-vs-Female
6.440800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.573200E-01
Normal-vs-Age(41-60Yrs)
5.683600E-01
Normal-vs-Age(61-80Yrs)
4.690000E-01
Normal-vs-Age(81-100Yrs)
4.164600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.592400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.842400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.581400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.288300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.668200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.606400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.822600E-01
Normal-vs-Daily Drinker
4.632200E-01
Normal-vs-Weekly Drinker
3.946800E-01
Normal-vs-Occasional Drinker
5.489000E-01
Normal-vs-Social Drinker
5.237400E-01
Non Drinker-vs-Daily Drinker
7.861600E-01
Non Drinker-vs-Weekly Drinker
2.260400E-01
Non Drinker-vs-Occasional Drinker
4.164800E-01
Non Drinker-vs-Social Drinker
6.725600E-01
Daily Drinker-vs-Weekly Drinker
4.736800E-01
Daily Drinker-vs-Occasional Drinker
3.917800E-01
Daily Drinker-vs-Social Drinker
5.945800E-01
Weekly Drinker-vs-Occasional Drinker
7.863700E-02
Weekly Drinker-vs-Social Drinker
1.980240E-01
Occasional Drinker-vs-Social Drinker
7.956400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.310100E-02
Normal-vs-Grade 2
1.318060E-02
Normal-vs-Grade 3
4.739200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.073000E-01
Grade 1-vs-Grade 3
4.719600E-01
Grade 1-vs-Grade 4
6.310100E-02
Grade 2-vs-Grade 3
1.310240E-01
Grade 2-vs-Grade 4
1.318060E-02
Grade 3-vs-Grade 4
4.739200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.565600E-01
Normal-vs-NonDiabetic
4.879000E-01
Diabetic-vs-NonDiabetic
5.115400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.895400E-01
Normal-vs-NoPancreatitis
4.828000E-01
Pancreatitis-vs-NoPancreatitis
9.904800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.918800E-01
Normal-vs-N1
5.010000E-01
N0-vs-N1
8.324000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.298800E-01
Normal-vs-TP53-NonMutant
5.110800E-01
TP53-Mutant-vs-TP53-NonMutant
7.708800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
